BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37024284)

  • 1. Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.
    Zacarías-Fluck MF; Massó-Vallés D; Giuntini F; González-Larreategui Í; Kaur J; Casacuberta-Serra S; Jauset T; Martínez-Martín S; Martín-Fernández G; Serrano Del Pozo E; Foradada L; Grueso J; Nonell L; Beaulieu ME; Whitfield JR; Soucek L
    Genes Dev; 2023 Apr; 37(7-8):303-320. PubMed ID: 37024284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
    Stefan E; Bister K
    Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.
    Massó-Vallés D; Beaulieu ME; Jauset T; Giuntini F; Zacarías-Fluck MF; Foradada L; Martínez-Martín S; Serrano E; Martín-Fernández G; Casacuberta-Serra S; Castillo Cano V; Kaur J; López-Estévez S; Morcillo MÁ; Alzrigat M; Mahmoud L; Luque-García A; Escorihuela M; Guzman M; Arribas J; Serra V; Larsson LG; Whitfield JR; Soucek L
    Cancer Res Commun; 2022 Feb; 2(2):110-130. PubMed ID: 36860495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct thresholds govern Myc's biological output in vivo.
    Murphy DJ; Junttila MR; Pouyet L; Karnezis A; Shchors K; Bui DA; Brown-Swigart L; Johnson L; Evan GI
    Cancer Cell; 2008 Dec; 14(6):447-57. PubMed ID: 19061836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring MYC-Mediated Metabolism in Tumorigenesis.
    Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
    Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
    Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
    Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
    Farrell AS; Pelz C; Wang X; Daniel CJ; Wang Z; Su Y; Janghorban M; Zhang X; Morgan C; Impey S; Sears RC
    Mol Cell Biol; 2013 Aug; 33(15):2930-49. PubMed ID: 23716601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ARF tumor suppressor: keeping Myc on a leash.
    Gregory MA; Qi Y; Hann SR
    Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
    Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
    Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.
    Kfoury A; Armaro M; Collodet C; Sordet-Dessimoz J; Giner MP; Christen S; Moco S; Leleu M; de Leval L; Koch U; Trumpp A; Sakamoto K; Beermann F; Radtke F
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29440228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC, Metabolism, and Cancer.
    Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
    Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC on the path to cancer.
    Dang CV
    Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNIP1: Myc's new helper in transcriptional activation.
    Larsson LG
    Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC leads the way.
    Venkateswaran N; Conacci-Sorrell M
    Small GTPases; 2020 Mar; 11(2):86-94. PubMed ID: 29173017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc's other life: stem cells and beyond.
    Laurenti E; Wilson A; Trumpp A
    Curr Opin Cell Biol; 2009 Dec; 21(6):844-54. PubMed ID: 19836223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional control of DNA replication licensing by Myc.
    Valovka T; Schönfeld M; Raffeiner P; Breuker K; Dunzendorfer-Matt T; Hartl M; Bister K
    Sci Rep; 2013 Dec; 3():3444. PubMed ID: 24309437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 regulates Myc protein stability and activity.
    Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
    Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.
    Savino M; Annibali D; Carucci N; Favuzzi E; Cole MD; Evan GI; Soucek L; Nasi S
    PLoS One; 2011; 6(7):e22284. PubMed ID: 21811581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc's secret life without Max.
    Gallant P; Steiger D
    Cell Cycle; 2009 Dec; 8(23):3848-53. PubMed ID: 19887915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.